' CEO and Managing Director, Dr Deborah Rathjen, described the combined Bionomics
, Neurofit and Iliad business as a "fully integrated drug discovery and development company.
This acquisition enables Bionomics
to expand its CNS development potential to neurodegenerative disorders including Parkinson's Disease, which are diseases of significant unmet clinical need that represent lucrative commercial opportunities.
The precise terms of the financial arrangements between GTG and Bionomics
are covered by confidentiality, but it can be disclosed that both parties will benefit from the revenues generated from this new alliance.
During the whole process, every scientist at WEHI and Bionomics
maintained a focus upon what we were trying to achieve: a treatment for MS, a debilitating disease that is tragically common among young adults.
Organizations working with Bionomics
in its epilepsy and anxiety drug discovery efforts now include the Walter and Eliza Hall Institute and Southern Cross University.
Studies on the bionomics
and ecology of the potato tuber moth, Gnorimoschema (Phthorimaea operculella) Zeller in Bulgaria and means for its control.
Under the agreement, Bionomics
will receive an upfront payment of US$ 2 million and committed research funding.
Dr Deborah Rathjen, CEO and Managing Director of Bionomics
, welcomed the addition of another highly regarded United States-based institution to Bionomics
' network of academic collaborators in epilepsy gene discovery and drug development.
and its collaborators, including Associate Professor Ingrid Scheffer and Professor Samuel Berkovic, the leading clinicians for the 100 patient clinical study which validated the test, will provide support to Athena in the promotion of the test to neurologists.
As a drug discovery and development organization focusing on new treatments for cancer and serious disorders of the central nervous system, Bionomics
selected ACR Image Metrix to perform the imaging components of this study.
ADELAIDE, Australia, April 17, 2015 /PRNewswire/ -- Bionomics
Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of cancer and diseases of the central nervous system, today announced the presentation of data from three of its most advanced oncology programs at the upcoming American Association for Cancer Research (AACR) 106[sup.
Fruit Flies of Economic Significance: Their Identification and Bionomics